Drug
Tgr 1202 Obinutuzumab Chlorambucil
Tgr 1202 Obinutuzumab Chlorambucil: highest development phase Phase 1, developed by TG Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- TG Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| TGR-1202 + Obinutuzumab + Chlorambucil NCT02100852 | Phase 1 | Chronic Lymphocytic Leukemia |
Latest
No recent events.
Follow Tgr 1202 Obinutuzumab Chlorambucil on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.